Cresco Labs Inc. (OTCQX: CRLBF) Q1 2025 Earnings Call 5/29/2025

About this video

Cresco Labs Inc. (OTCQX: CRLBF) reported Q1 2025 results on May 29, 2025, delivering revenue of $166 million—right in line with guidance—as the company continued to prioritize disciplined growth and financial flexibility. Adjusted gross profit was $82 million, with an adjusted gross margin of 49%, and adjusted EBITDA reached $36 million, representing a 22% margin. Operating cash flow was a robust $30 million, and Cresco ended the quarter with $162 million in cash, its highest balance in three years, underscoring strong liquidity and prudent capital management. Retail revenue declined 5% sequentially, reflecting seasonal trends and increased competition, while wholesale revenue also fell as Cresco strategically limited sales to accounts with higher credit risk. Despite these headwinds, the company maintained its number one market share in Illinois and Pennsylvania and continued to expand its footprint, opening its 18th dispensary in Pennsylvania and planning new locations in Ohio and Kentucky. Customer loyalty remains high, with over 60% of customers engaged in the rewards program and nearly 400,000 active members. Looking ahead, Cresco Labs anticipates slight revenue and margin pressure in Q2 2025 due to Illinois’ mandatory seed-to-sale system conversion, but management remains confident in the company’s long-term strategy. Cresco is focused on sustainable growth, margin expansion, and further strengthening its balance sheet to support future opportunities. About Inside Ticker: For more expert analysis and real-time updates on Cresco Labs Inc. (OTCQX: CRLBF) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #CrescoLabs #CRLBF #EarningsCall #Q12025 #Cannabis #Retail #Wholesale #StockMarket #Investing #InsideTicker